
Baxter International Inc. (NYSE:BAX – Free Report) – Equities researchers at Zacks Research cut their Q4 2026 earnings per share estimates for shares of Baxter International in a research note issued to investors on Thursday, November 19th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings of $0.59 per share for the quarter, down from their previous estimate of $0.60. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.10 per share. Zacks Research also issued estimates for Baxter International’s Q1 2028 earnings at $0.44 EPS.
Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. reduced their target price on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating for the company in a report on Friday, October 30th. UBS Group raised their target price on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $25.00 price target on shares of Baxter International in a research note on Thursday, October 29th. TD Cowen boosted their price target on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Finally, Wells Fargo & Company boosted their price target on shares of Baxter International from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Friday, October 30th. One analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $23.27.
Get Our Latest Stock Analysis on Baxter International
Baxter International Price Performance
NYSE BAX opened at $25.38 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.79 and a debt-to-equity ratio of 1.20. Baxter International has a 12-month low of $15.73 and a 12-month high of $30.00. The company has a market capitalization of $13.13 billion, a PE ratio of -18.00, a price-to-earnings-growth ratio of 3.84 and a beta of 0.68. The firm’s 50 day moving average is $24.61 and its 200-day moving average is $21.79.
Baxter International (NYSE:BAX – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. The firm had revenue of $2.98 billion during the quarter, compared to the consensus estimate of $2.91 billion. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The business’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.69 EPS.
Institutional Investors Weigh In On Baxter International
Institutional investors and hedge funds have recently made changes to their positions in the stock. Jones Financial Companies Lllp bought a new stake in shares of Baxter International during the 2nd quarter worth approximately $26,000. Nemes Rush Group LLC boosted its holdings in shares of Baxter International by 2,915.9% in the 3rd quarter. Nemes Rush Group LLC now owns 1,327 shares of the medical instruments supplier’s stock valued at $32,000 after buying an additional 1,283 shares during the last quarter. Global Retirement Partners LLC grew its stake in shares of Baxter International by 45.8% in the third quarter. Global Retirement Partners LLC now owns 1,566 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 492 shares in the last quarter. CYBER HORNET ETFs LLC grew its stake in shares of Baxter International by 52.4% in the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 740 shares in the last quarter. Finally, Community Bank N.A. bought a new position in shares of Baxter International in the second quarter valued at $46,000. Institutional investors own 90.19% of the company’s stock.
Baxter International Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s payout ratio is -2.84%.
Baxter International Company Profile
Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.
Recommended Stories
- Five stocks we like better than Baxter International
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
